These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16141618)

  • 21. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model.
    Wu Y; Na X; Zang Y; Cui Y; Xin W; Pang R; Zhou L; Wei X; Li Y; Liu X
    Biochem Biophys Res Commun; 2014 Jul; 449(4):502-7. PubMed ID: 24845379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholamine reuptake and storage. Overview.
    Bönisch H; Eiden L
    Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma membrane monoamine transporters: structure, regulation and function.
    Torres GE; Gainetdinov RR; Caron MG
    Nat Rev Neurosci; 2003 Jan; 4(1):13-25. PubMed ID: 12511858
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction.
    Simantov R
    Neurosci Lett; 1993 Dec; 163(2):121-4. PubMed ID: 8309616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights.
    Lew R; Vaughan R; Simantov R; Wilson A; Kuhar MJ
    Synapse; 1991 Jun; 8(2):152-3. PubMed ID: 1882335
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
    Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
    J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug abuse and alcoholism. Overview.
    Koob GF
    Adv Pharmacol; 1998; 42():969-77. PubMed ID: 9328060
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid regulation of the dopamine transporter: role in stimulant addiction?
    Zahniser NR; Sorkin A
    Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-transporter density in nucleus accumbens of type-1 alcoholics.
    Tupala E; Hall H; Särkioja T; Räsänen P; Tiihonen J
    Lancet; 2000 Jan; 355(9201):380. PubMed ID: 10665563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
    Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
    Yu H; Kim IJ; Folk JE; Tian X; Rothman RB; Baumann MH; Dersch CM; Flippen-Anderson JL; Parrish D; Jacobson AE; Rice KC
    J Med Chem; 2004 May; 47(10):2624-34. PubMed ID: 15115403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic studies on substance dependence].
    Ujiie H; Inada T; Harano M; Komiyayama T; Yamada M; Sekine Y; Sora I; Iwata N; Iyo M; Ozaki N
    Seishin Shinkeigaku Zasshi; 2004; 106(12):1598-603. PubMed ID: 15770963
    [No Abstract]   [Full Text] [Related]  

  • 34. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss.
    Harvey DC; Lacan G; Tanious SP; Melega WP
    Brain Res; 2000 Jul; 871(2):259-70. PubMed ID: 10899292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes.
    Amenta F; Bronzetti E; Cantalamessa F; El-Assouad D; Felici L; Ricci A; Tayebati SK
    J Neuroimmunol; 2001 Jul; 117(1-2):133-42. PubMed ID: 11431013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice.
    Hall FS; Sora I; Uhl GR
    Neuropsychopharmacology; 2003 Apr; 28(4):620-8. PubMed ID: 12655306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug abuse and mental illness: progress in understanding comorbidity.
    Volkow ND
    Am J Psychiatry; 2001 Aug; 158(8):1181-3. PubMed ID: 11481146
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement.
    Sarnyai Z; McKittrick CR; McEwen BS; Kreek MJ
    Synapse; 1998 Nov; 30(3):334-7. PubMed ID: 9776137
    [No Abstract]   [Full Text] [Related]  

  • 40. Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum.
    Zucker M; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):199-201. PubMed ID: 15695065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.